Approval · Notice of Compliance 17875 · 2016
NAPRELAN: Notice of Compliance 17875
Issued March 15, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17875
- Date
- March 15, 2016
- Company
- Alkermes IncWaltham, Massachusetts, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
Medicinal ingredients
- NAPROXEN SODIUM 375 MG per TAB
- NAPROXEN SODIUM 500 MG per TAB